POSTER SESSION 1

1

(INF, AHE)

* COST-EFFECTIVENESS OF FOUR DIFFERENT STRATEGIES FOR EVALUATION OF FEVER IN INFANTS LESS THAN 60 DAYS OF AGE

Eileen Murtagh Kurowski, MD, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, Daniel P. Schauer, MD, MSc, Internal Medicine, Cincinnati, USA and Mark H. Eckman, MD, MS, University of Cincinnati, Cincinnati, OH

2

(INF, AHE)

* COST-EFFECTIVENESS OF ROUTINE USE OF MAGNESIUM SULFATE FOR SEIZURE PROPHYLAXIS IN MILD PREECLAMPSIA

Jonathan Glazer Shaw, MD¹, Jeremy D. Goldhaber-Fiebert, PhD², Mackensie Yore³, Serena Faruque, MS³, Aaron B. Caughey, MD, MPP, MPH, PhD⁴ and Douglas K. Owens, MD, MS¹, (1)Veterans Affairs Palo Alto Health Care System and Stanford University, Stanford, CA, (2)Centers for Health Policy & Primary Care and Outcomes Research, Stanford University, Stanford, CA, (3)Stanford University, Stanford, CA, (4)Oregon Health & Sciences University, Portland, OR

3

(INF, AHE)

* IMPLICATIONS OF USING EFFECTIVENESS INSTEAD OF EFFICACY ON THE COST-EFFECTIVENESS OF BIOLOGICS IN RHEUMATOID ARTHRITIS: A MULTI-STUDY SENSITIVITY ANALYSIS

Hawre Jalal, MD, MSc¹, Kaleb D. Michaud, PhD², Frederick Wolfe, M.D.³ and Karen M. Kuntz, ScD¹, (1)University of Minnesota, Minneapolis, MN, (2)University of Nebraska Medical Center (UNMC), Omaha, NE, (3)National Data Bank for Rheumatic Diseases, Wichita, KS

4

(INF, AHE)

* LINEAR REGRESSION METAMODELING AS A TOOL TO SUMMARIZE AND PRESENT SIMULATION MODEL OUTPUTS

Hawre Jalal, MD, MSc, Bryan E. Dowd, PhD, François Sainfort, PhD and Karen M. Kuntz, ScD, University of Minnesota, Minneapolis, MN

5

(AHE)

* THE ECONOMIC BURDEN OF CHILDHOOD AUTISM SPECTRUM DISORDERS

Tara A. Lavelle, MS, PhD¹, Milton C. Weinstein, PhD², Joseph P. Newhouse, PhD¹, Kerim Munir, MD, MPH, ScD³, Karen A. Kuhlthau, PhD⁴ and Lisa A. Prosser, M.S., Ph.D.⁵, (1)Harvard University, Cambridge, MA, (2)Harvard School of Public Health, Boston, MA, (3)Children's Hospital Boston, Boston, MA, (4)Massachusetts General Hospital, Boston, MA, (5)University of Michigan, Ann Arbor, MI

6

(INF, AHE)

COST-EFFECTIVENESS ANALYSIS OF NEW DIRECT-ACTING ANTIVIRALS (DAAS) THERAPY FOR PATIENTS WITH UNTREATED CHRONIC HEPATITIS C GENOTYPE 1 INFECTION IN THE VETERANS HEALTH ADMINISTRATION

Kee Chan, PhD¹, Mai Ngan Lai, BS², Erik Groessl, PhD², Amresh Hanchate, PhD¹, John Wong, MD³, Jack Clark, PhD¹, Steven Asch, PhD⁴, Allen Gifford, MD⁵ and Samue Ho, MD⁶, (1)Boston University, Boston, MA, (2)University of California, San Diego, La Jolla, CA, (3)Tufts Medical Center, Boston, MA, (4)HSR&D Center for Health Care Evaluation, Menlo Park, CA, (5)Bedford Center for Health Quality, Outcomes & Economic Research, Bedford, MA, (6)Gastroenterology, San Diego, CA

7

(INF, AHE)

COST EFFECTIVENESS OF FIRST LINE CHEMOTHERAPY FOR PATIENTS WITH ADVANCED OR METASTATIC NON SMALL CELL LUNG CANCER

Adrian Bagust, BA, MSc, Angela Boland, BA, MSc, PhD and Rumona Dickson, PhD, University of Liverpool, Liverpool, United Kingdom

8

(INF, AHE)

THE VALUE OF INFORMATION OF ADDITIONAL RESEARCH REGARDING BIRTH-COHORT SCREENING FOR HEPATITIS C

David Rein, PhD¹, John Wittenborn, Wittenborn-John@norc.org¹ and Bryce Smith, PhD², (1)NORC at the University of Chicago, Atlanta, GA, (2)CDC, Atlanta, GA

9

(INF, AHE)

COST-EFFECTIVENESS OF ROTAVIRUS VACCICINATION IN A MIDDLE INCOME COUNTRY: A DYNAMIC MODELLING APPROACH

Ivar Sønbø Kristiansen, MD, PhD, MPH and Birgitte Freiesleben de Blasio, PHD, University of Oslo, Oslo, Norway

10

(INF, AHE)

COST-EFFECTIVENESS ANALYSIS AND BUDGET IMPACT ASSESSMENT: COMBINING THE TWO FOR THE AID OF DECISION MAKERS

Mike Paulden, MA., MSc. and Ba Pham, MSc, University of Toronto, Toronto, ON, Canada

11

(INF, AHE)

ADVANCING THE METHODS OF COST-EFFECTIVENESS ANALYSIS: WHY IT'S TIME TO MOVE ON FROM ICERS AND THRESHOLDS

Mike Paulden, MA., MSc., University of Toronto, Toronto, ON, Canada

12

(INF, AHE)

PROJECTED COST-EFFECTIVENESS OF A BARBERSHOP-BASED INTERVENTION TO REDUCE HYPERTENSION IN BLACK MEN

Nrupen A. Bhavsar, PhD¹, Joseph E. Ravenell², Gbenga Ogedegbe², Jason A. Roy³, R. Scott Braithwaite, MD, MSc, FACP² and Joseph A. Ladapo, MD, PhD², (1)Johns Hopkins University School of Medicine, Baltimore, MD, (2)New York University School of Medicine, New York, NY, (3)University of Pennsylvania School of Medicine, Philadelphia, PA

13

(INF, AHE)

COST-EFFECTIVENESS OF ENHANCED DEPRESSION CARE FOR PATIENTS WITH ACUTE CORONARY SYNDROME AND DEPRESSIVE SYMPTOMS: RESULTS OF THE COPES RANDOMIZED CONTROLLED TRIAL

Joseph A. Ladapo, MD, PhD¹, Jonathan A. Shaffer, PhD², Yixin Fang, PhD¹, Lauren M. Uhler, BA¹, Siqin Ye, MD² and Karina W. Davidson, PhD², (1)New York University School of Medicine, New York, NY, (2)Columbia University College of Physicians and Surgeons, New York, NY

14

(INF, AHE)

A COST-EFFECTIVENESS ANALYSIS COMPARING TWO ALTERNATIVE DEBRIDEMENT THERAPIES FOR NECROTIC PRESSURE ULCERS IN A LONG-TERM CARE SETTING

Curtis Waycaster, PhD, Healthpoint Biotherapeutics, Fort Worth, TX

15

(AHE)

ESTIMATING LIFETIME HIV TREATMENT COSTS IN THE UNITED STATES: EARLY VERSUS LATE ENTRY INTO CARE

Paul G. Farnham, Ph.D.¹, Chaitra Gopalappa, Ph.D.², Stephanie Sansom, PhD¹ and Angela Hutchinson, PhD, MPH³, (1)Centers for Disease Control and Prevention, Atlanta, GA, (2)Futures Institute, Manchester, CT, (3)Division of HIV/AIDS Prevention, Atlanta, GA

16

(DEC)

* WHO INITIATES CANCER SYMPTOM MANAGEMENT DISCUSSIONS? FACTORS ASSOCIATED WITH PATIENT VS. CLINICIAN INITIATION IN WOMEN WITH OVARIAN CANCER

Yun Jiang, BSN, MS, RN¹, Paula R. Sherwood, PhD, RN¹, Susan M. Sereika, PhD¹, Robert P. Edwards, MD² and Heidi S. Donovan, PhD, RN¹, (1)University of Pittsburgh Schoool of Nursing, Pittsburgh, PA, (2)University of Pittsburgh Medical Center Magee Women's Hospital, Pittsburgh, PA

17

(DEC)

* ADOPTING CLINICAL PRACTICE GUIDELINES NEGATIVELY IMPACT SHARING DECISIONS WITH PATIENTS BUT TRAINING HEALTH PROFESSIONALS IN SDM CANCELS THIS IMPACT

Mireille Guerrier, Msc, Research Center of the CHUQ, Québec, Quebec, QC, Canada, Michel Labrecque, MD, PhD, Universite Laval, Quebec, QC, Canada, Stéphane Turcotte, M.Sc., CHUQ Research Center-Hospital St-François d'Assise, Knowledge Transfer and Health Technology Assessment, Québec, QC, Canada, Louis-Paul Rivest, PhD, Dpt of Mathematics and Statistics, Université Laval, Quebec, QC, Canada and France Légaré, MD, PhD, CHUQ Research Center-Hospital St-François d'Assise, Knowledge Transfer and Health Technology Assessment, Quebec, QC, Canada

18

(DEC)

DETERMINANTS OF COUNSELING REGARDING TRIAL OF LABOR AFTER CESAREAN: THE IMPACT OF PROVIDER CHARACTERISTICS

Katharine Newman, MD, Brigham and Women's Hospital/Massachusetts General Hospital Integrated Residency in Obstetrics and Gynecology, Boston, MA, Bruce Feinberg, MD, Brigham and Women's Hospital, Boston, MA and Anjali Kaimal, MD, MAS, Massachusetts General Hospital, Harvard Medical School, Boston, MA

19

(DEC)

* EFFECTS OF DECISION AMBIGUITY AND CONFLICTS OF INTEREST ON PERCEIVED VALUE OF A MEDICAL SERVICE

Sorapop Kiatpongsan, MD, Harvard Interfaculty Initiative in Health Policy, Cambridge, MA, Anjali Kaimal, MD, MAS, Massachusetts General Hospital, Harvard Medical School, Boston, MA, Michael I. Norton, PhD, Harvard Business School, Boston, MA and Milton C. Weinstein, PhD, Harvard School of Public Health, Boston, MA

20

(DEC)

WHAT ATTRIBUTES OF A LUNG CANCER SCREENING TEST AFFECT INTEREST IN BEING SCREENED?

Margaret M. Byrne, PhD¹, Richard Thurer¹, Mark S. Roberts, MD, MPP² and Jamie L. Studts, PhD³, (1)University of Miami, Miami, FL, (2)University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, (3)University of Kentucky College of Medicine, Lexington, KY

21

(DEC)

WILLINGNESS TO CHANGE TREATMENT SHOULD BE ASSESSED AT MULTIPLE TIME POINTS

Paul R. Falzer, PhD, Yale School of Medicine, West Haven, CT and Liana Fraenkel, MD, MPH, Yale School of Medicine, New Haven, CT

22

(DEC)

INFORMATION-SEEKING BEHAVIOR AND DECISION MAKING IN PATIENTS UNDERGOING ELECTIVE CARDIAC PROCEDURES

Grace A. Lin, MD, MAS¹, Katherine Hicks, B.A.¹, Julie Bynum, M.D., M.P.H.², Carol Cosenza, MSW³, Karen R. Sepucha, PhD⁴, Kim Smolderen, PhD⁵ and R. Adams Dudley, MD, MBA¹, (1)University of California, San Francisco, San Francisco, CA, (2)Dartmouth Medical School, Lebanon, NH, (3)University of Massachusetts Boston, Boston, MA, (4)Massachusetts General Hospital, Boston, MA, (5)St. Luke's Hospital, Kansas City, MO

23

(DEC)

SUPPORTING PATIENT DECISION-MAKING FOR SURGERY VERSUS PROLONGED CONSERVATIVE TREATMENT FOR HERNIATED DISK: EVALUATION OF ENRICHED VIDEO AND TEXTUAL WEB-BASED PATIENT DECISION AIDS IN A MULTI-CENTER RANDOMIZED TRIAL

Marieke de Vries, PhD¹, Monique C.M. Baas-Thijssen², Anne M. Stiggelbout, PhD², Carmen Vleggeert, MD² and Wilco C. Peul, MD, MSc², (1)Leiden University Medical Center & Tilburg University, Leiden, Netherlands, (2)Leiden University Medical Center, Leiden, Netherlands

24

(DEC)

PATIENT'S DESIRE FOR INFORMATION: A STUDY IN THE ADVANCED CANCER SETTING

Linda J.M. Oostendorp, MSc¹, Petronella B. Ottevanger, MD, PhD¹, Winette T.A. Van der Graaf, Prof, MD¹ and Peep F.M. Stalmeier, PhD², (1)Radboud University Nijmegen Medical Center, Nijmegen, Netherlands, (2)Radboud UMC, Nijmegen, Netherlands

25

(DEC)

RESULTS FROM A DECISION MAKING SURVEY OF LATINA BREAST CANCER PATIENTS

Sandra Feibelmann, M.P.H.¹, Karen R. Sepucha, PhD¹, Sarah Hewitt, B.A.¹ and Argyrios Ziogas, Ph.D.², (1)Massachusetts General Hospital, Boston, MA, (2)University of California Irvine, School of Medicine, Irvine, CA

26

(DEC)

RACE AND TOTAL JOINT REPLACEMENT (TJR) CONSIDERATION: THE ROLE OF SOCIAL SUPPORT

Ernest R. Vina, MD, MS¹, Yona K. Coonan, PhD², Said Ibrahim, M.D., M.P.H.³, Michael J. Hannon, MA², Robert M. Boudreau, PhD² and C. Kent Kwoh, MD¹, (1)University of Pittsburgh and VAPHS, Pittsburgh, PA, (2)University of Pittsburgh, Pittsburgh, PA, (3)University of Pennsylvania, Philadelphia, PA

27

(INF, DEC)

DEVELOPING A THEORY-BASED MEASURE OF PATIENT SHARED DECISION MAKING COMMUNICATION BEHAVIORS

Dominick Frosch, PhD¹, Jared R. Adams, MD, PhD¹, France Legare, MD, PhD, CCFP, F², Caroline Tietbohl, BA¹ and Glyn Elwyn, MD, PhD³, (1)Palo Alto Medical Foundation Research Institute, Palo Alto, CA, (2)Laval University, Quebec, QC, Canada, (3)Dartmouth Center for Healthcare Delivery Science, Hanover, NH

28

(DEC)

ON STRATEGIES TO CONTROL HEALTHCARE COSTS: INFLUENCING PATIENTS TO “SELF-RATION” BY COMMUNICATING THE SOCIAL IMPLICATIONS OF OVERUSE

Laura Scherer, PhD¹, Peter A. Ubel, MD², Darin Zahuranec³, James Burke³, Sameer Saini, MD, MS³ and Angela Fagerlin, PhD⁴, (1)VA HSR&D and University of Michigan, Ann Arbor, MI, (2)Duke University, Durham, NC, (3)University of Michigan, Ann Arbor, MI, (4)VA Ann Arbor Healthcare System & University of Michigan, Ann Arbor, MI

29

(DEC)

PHYSICIAN OVERUTILIZATION OF SLEEP STUDIES IN PREDICTING PATIENT IMPROVEMENT USING CPAP

Robert M. Hamm, PhD¹, Rory Ramsey, MD², Neal V. Dawson, MD³, William A. Whitelaw, MD⁴, Ward W. Flemons, MD⁴, Rollin F. Brant, MD⁵ and Kingman P. Strohl, MD⁶, (1)University of Oklahoma Health Sciences Center, Oklahoma City, OK, (2)St. Alphonsis Regional Medical Center, Boise, ID, (3)Case Western Reserve University at MetroHealth Medical Center, Cleveland, OH, (4)University of Calgary, Calgary, AB, Canada, (5)University of British Columbia, Vancouver, BC, Canada, (6)Case Medical Center, Cleveland, OH

30

(DEC)

LONG-TERM BREAST CANCER SURVIVORS' PERCEPTIONS OF CANCER RISK: A MENTAL MODELS STUDY

Christopher A. Harle, PhD, Jessica R. Schumacher, PhD, Damian M. Everhart, MS, Lori A. Bilello, MS and Merry-Jennifer Markham, MD, University of Florida, Gainesville, FL

31

(HSP)

* IDENTIFYING FACTORS ASSOCIATED WITH STATE PSYCHIATRIC HOSPITAL USE TO INFORM ADMISSION, REFERRAL, AND POLICY DECISION-MAKING

Elizabeth Holdsworth La, MSE¹, Kristen Hassmiller Lich, PhD¹, Ruoqing Zhu¹, Alan R. Ellis, MSW², Marvin Swartz, MD³, Michael R. Kosorok, PhD¹ and Joseph Morrissey, PhD¹, (1)University of North Carolina at Chapel Hill, Chapel Hill, NC, (2)Cecil G. Sheps Center for Health Services Research, Chapel Hill, NC, (3)Duke University, Durham, NC

32

(INF, HSP)

* MODELING THE ADDED PREDICTIVE VALUE OF A NOVEL CARDIOVASCULAR RISK MARKER WITH A SIMPLE MARKOV MODEL

Bart S. Ferket, MD¹, Bob J.H. van Kempen, MSc¹, Ewout W. Steyerberg, PhD², Oscar H. Franco, MD, PhD, FESC, MFPH³, Wendy Max, PhD⁴, Kirsten E. Fleischmann, MD, MPH⁵ and M.G. Myriam Hunink, MD, PhD⁶, (1)Erasmus MC, Rotterdam, Netherlands, (2)Department of Public Health, AE 236, Rotterdam, Netherlands, (3)Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands, (4)University of California, San Francisco, San Francisco, CA, (5)UCSF Medical Center, San Francisco, CA, (6)Erasmus University Medical Center, Rotterdam, Netherlands

33

(HSP)

* OPTIMIZING CERVICAL CANCER SCREENING PARTICIPATION

Emily A. Burger, MPhil¹, Ivar Sønbø Kristiansen, MD, PhD, MPH¹ and Jane J. Kim, PhD², (1)University of Oslo, Oslo, Norway, (2)Harvard School of Public Health, Boston, MA

34

(INF, HSP)

* COST-EFFECTIVENESS OF TREATMENT OPTIONS FOR DIABETIC MACULAR EDEMA

Suzann Pershing, M.D.¹, Brian Matesic¹, Eva Enns, MS, PhD, Candidate¹, Douglas K. Owens, MD, MS² and Jeremy D. Goldhaber-Fiebert, PhD¹, (1)Stanford University, Stanford, CA, (2)Veterans Affairs Palo Alto Health Care System and Stanford University, Stanford, CA

35

(HSP)

* PROGNOSTIC MODEL OF MORTALITY FOLLOWING HUMAN INFLUENZA (A) H5N1 INFECTION

Rita B. Patel, MD, MPH¹, Maya Mathur¹, Yoshi Gillaspie, BA¹, Yang Xiao, PhD² and Nayer Khazeni, MD, MS¹, (1)Stanford University, Stanford, CA, (2)University of California, Davis, Davis, CA

36

(HSP)

* CHARACTERIZING THE FLOW OF SHORT-STAY PATIENTS IN THE INTENSIVE CARE UNIT

Kusum S. Mathews, MD, MPH¹, Grace Y. Jenq, MD¹, Margaret A. Pisani, MD, MPH¹ and Elisa F. Long, PhD², (1)Yale School of Medicine, New Haven, CT, (2)Yale University, New Haven, CT

37

(HSP)

CREATION OF A GENOMIC PRESCRIBING SYSTEM FOR DELIVERY OF PHARMACOGENOMIC RESULTS AND PERSONALIZED PRESCRIPTION DECISION-MAKING

Peter H. O'Donnell, M.D., Angela Bush, Jared Spitz, Keith Danahey, Don Saner, Soma Das, Nancy J. Cox and Mark J. Ratain, MD, The University of Chicago, Chicago, IL

38

(HSP)

IMPACT OF MULTIPLE MEDICATION COMPLIANCE ON DISEASE BURDEN IN A CALIFORNIA MEDICAID POPULATION WITH COMORBID TYPE II DIABETES AND CARDIOVASCULAR DISEASE

Joanne Wu, MD, MS and Michael B. Nichol, PhD, University of Southern California, Los Angeles, CA

39

(HSP)

PATTERNS AND CORRELATES OF LINKAGE TO APPROPRIATE HIV CARE FOLLOWING HIV DIAGNOSIS IN THE UNITED STATES MEDICAID POPULATION

Stephen S. Johnston, MA¹, Timothy Juday, PhD², Daniel Seekins, MD², Tony Hebden, PhD², Nicole Fulcher, MA³, Amanda Farr, MPH¹, Bong-Chul Chu, PhD⁴ and C.Daniel Mullins, PhD⁵, (1)Thomson Reuters, Washington, DC, (2)Bristol-Myers Squibb, Plainsboro, NJ, (3)Thomson Reuters, Cambridge, MA, (4)Thomson Reuters, Santa Barbara, CA, (5)University of Maryland School of Pharmacy, Baltimore, MD

40

(HSP)

NET EFFECT OF CURRENT PATTERNS OF ORAL CONTRACEPTIVE USE ON POTENTIALLY FATAL OUTCOMES IN THE UNITED STATES

Evan R. Myers, MD, MPH¹, Laura J. Havrilesky, MD¹, Jennifer Gierisch, PhD, MPH¹, Patricia G. Moorman, PhD¹, Michaela A. Dinan, PhD², Remy R. Coeytaux, MD, PhD¹, Rachel P. Urrutia, MD³, William J. Lowery, MD¹, Vic Hasselblad, PhD¹, Amanda J. McBroom, PhD² and Gillian D. Sanders, PhD¹, (1)Duke University School of Medicine, Durham, NC, (2)Duke Clinical Research Institute, Durham, NC, (3)UNC School of Medicine, Chapel Hill, NC

41

(INF, HSP)

USING NET BENEFITS AND ACCEPTABILITY CURVES TO QUANTIFY UNCERTAINTY ABOUT TRADEOFFS BETWEEN HARMS AND BENEFITS OF ORAL CONTRACEPTIVES

Evan R. Myers, MD, MPH¹, Laura J. Havrilesky, MD¹, Jennifer Gierisch, PhD, MPH¹, Patricia G. Moorman, PhD¹, Michaela A. Dinan, PhD², Remy R. Coeytaux, MD, PhD¹, Rachel P. Urrutia, MD³, William J. Lowery, MD¹, Vic Hasselblad, PhD¹, Amanda J. McBroom, PhD² and Gillian D. Sanders, PhD¹, (1)Duke University School of Medicine, Durham, NC, (2)Duke Clinical Research Institute, Durham, NC, (3)UNC School of Medicine, Chapel Hill, NC

44

(HSP)

OPPORTUNITIES AND CHALLENGES IN USING ADMINISTRATIVE DATA FOR CROSS-COUNTRY COMPARISONS OF HEALTH CARE COSTS

Karen E. Bremner, BSc¹, Murray D. Krahn, MD, MSc², K. Robin Yabroff, PhD³, Jeffrey S. Hoch, PhD⁴, Lisa Barbera, MD², Ning Liu⁵, Michael J. Barrett⁶ and Joan L. Warren, PhD³, (1)University Health Network, Toronto, ON, Canada, (2)University of Toronto, Toronto, ON, Canada, (3)National Cancer Institute, Bethesda, MD, (4)Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, ON, Canada, (5)Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, (6)Information Management Services, Silver Spring, MD

45

(INF, MET)

* USING THE NET MONETARY BENEFIT FRAMEWORK FOR THE OPTIMAL DICHOTOMIZATION OF DIAGNOSTIC TESTS: A CASE STUDY OF A DYSGLYCEMIA SCREENING PROGRAM

Gimon de Graaf, Douwe Postmus, PhD and Erik Buskens, PhD, University Medical Center Groningen, Groningen, Netherlands

46

(MET)

* USING PROBABILITY ELICITATION TO PERFORM EARLY HEALTH ECONOMIC EVALUATIONS OF NEW MEDICAL PRODUCTS

Qi Cao, Msc., Douwe Postmus, PhD, Hans Hillege, PhD, MD and Erik Buskens, PhD, University Medical Center Groningen, Groningen, Netherlands

47

(MET)

* OPTIMIZATION OF HYPERGLYCEMIA TREATMENT INTENSIFICATION FOR PATIENTS WITH TYPE 2 DIABETES

Yuanhui Zhang, M.O.R¹, Jennifer E. Mason, PhD², Brian T. Denton, PhD¹, Nilay D. Shah, PhD³ and Steven Smith, MD⁴, (1)North Carolina State University, Raleigh, NC, (2)University of Virginia, Charlottesville, VA, (3)Mayo Clinic, Rochester, MN, (4)Mayo Clinic College of Medicine, Rochester, MN

48

(MET)

* MULTIPLE SIGNAL DETECTION APPLIED TO GIST-BASED DISCRIMINATION OF GENETIC RISK IN BREAST CANCER

Christopher R. Fisher, M.A.¹, Christopher R. Wolfe, Ph.D.¹, Valerie Reyna, PhD², Colin L. Widmer, BA¹, Elizabeth M. Cedillos, M.A.¹ and Priscila G. Brust-Renck, M.A.², (1)Miami University, Oxford, OH, (2)Cornell University, Ithaca, NY

49

(INF, MET)

* BAYESIAN CONTACT TRACING FOR COMMUNICABLE RESPIRATORY DISEASE

Ayman M. Shalaby, M.Eng and Daniel J. Lizotte, PhD, University of Waterloo, Waterloo, ON, Canada

50

(INF, MET)

* SIMULATING COLLATERAL WEIGHT LOSS WITHIN SOCIAL NETWORKS: CAPITALIZING ON SPILLOVER EFFECTS TO IMPROVE HEALTH

Davene R. Wright, PhD, University of Washington, Seattle, WA, Jane J. Kim, PhD, Harvard School of Public Health, Boston, MA and Lisa A. Prosser, M.S., Ph.D., University of Michigan, Ann Arbor, MI

51

(INF, MET)

COST-EFFECTIVENESS ANALYSIS WITH MARKOV DECISION PROCESSES

Jagpreet Chhatwal, PhD, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, Maryam H. Mofrad, MS, University of Pittsburgh, Pittsburgh, PA and Mark S. Roberts, MD, MPP, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA

52

(INF, MET)

RANDOM REGRET MINIMIZATION: A NEW DISCRETE CHOICE MODEL FOR HEALTH ECONOMICS

Esther W. de Bekker-Grob, PhD, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands and Caspar G. Chorus, PhD, Delft University of Technology, Delft, Netherlands

53

(INF, MET)

SENSITIVITY ANALYSIS METHODS FOR DECISION MODELS: A REVIEW AND TWO NOVEL TECHNIQUES

François Sainfort, PhD and Hawre Jalal, MD, MSc, University of Minnesota, Minneapolis, MN

54

(INF, MET)

NON-ADDITIVE MEASURES IN MEDICAL DECISION MAKING

Francois P. Modave, Ph.D. and Navkiran S. Shokar, MD, /, MPH, Texas Tech University HSC at El Paso, El Paso, TX

55

(INF, MET)

TOO MUCH OF A GOOD THING? WHEN TO STOP CATCH-UP VACCINATION

David W. Hutton, PhD, University of Michigan School of Public Health, Ann Arbor, MI and Margaret L. Brandeau, PhD, Stanford University, Stanford, CA

56

(INF, MET)

DECISION MAKING IN HETEROGENEOUS UNCERTAINTY ENVIRONMENT

Phan H. Giang, PhD, George Mason University, Fairfax, VA

57

(INF, MET)

ESTIMATING THE EXPECTED VALUE OF PERFECT PARAMETER INFORMATION (EVPPI): APPLICATIONS OF SHORT-CUT ALGORITHMS

John Wittenborn, Wittenborn-John@norc.org, NORC at the University of Chicago, Morrisville, NC and David Rein, PhD, NORC at the University of Chicago, Atlanta, GA

59

(HSP)

* GROWING WISER AND WIDER: THE COST-BENEFIT OF UNIVERSAL DESIGN IN MITIGATING LIMITED MOBILITY IN URGENT CARE SETTING

Lynn Huynh, MBA, MPH, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD and James Stahl, MD, CM, MPH, Massachusetts General Hospital, Boston, MA

60

(INF, MET)

* COST-EFFICIENT DESIGN OF EPIDEMIOLOGICAL STUDIES USING DISCRETE EVENT SIMULATION MODEL – EPISOL STUDY SIMULATOR 1.0

Lynn Huynh, MBA, MPH¹, Kevin D. Frick, PhD¹, Milo A. Puhan, MD, PhD¹ and James Stahl, MD, CM, MPH², (1)Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, (2)Massachusetts General Hospital, Boston, MA